- Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials CNBC
- Covid News: Live Updates The New York Times
- Molnupiravir, a drug developed by Merck, could be the first oral antiviral medicine for covid-19 The Washington Post
- Pill Intended to Be Covid-19’s Tamiflu Succeeds in Key Study The Wall Street Journal
- Merck's antiviral pill reduces hospitalization of Covid patients STAT
- View Full Coverage on Google News
Friday, October 1, 2021
Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials - CNBC
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment